Nanomaterials - Safety

Safety

Nanomaterials behave differently than other similarly-sized particles. It is therefore necessary to develop specialized approaches to testing and monitoring their effects on human health and on the environment. The OECD Chemicals Committee has established the Working Party on Manufactured Nanomaterials to address this issue and to study the practices of OECD member countries in regards to nanomaterial safety.

While nanomaterials and nanotechnologies are expected to yield numerous health and health care advances, such as more targeted methods of delivering drugs, new cancer therapies, and methods of early detection of diseases, they also may have unwanted effects. Increased rate of absorption is the main concern associated with manufactured nanoparticles.

When materials are made into nanoparticles, their surface area to volume ratio increases. The greater specific surface area (surface area per unit weight) may lead to increased rate of absorption through the skin, lungs, or digestive tract and may cause unwanted effects to the lungs as well as other organs. However, the particles must be absorbed in sufficient quantities in order to pose health risks.

As the use of nanomaterials increases worldwide, concerns for worker and user safety are mounting. To address such concerns, the Swedish Karolinska Institute conducted a study in which various nanoparticles were introduced to human lung epithelial cells. The results, released in 2008, showed that iron oxide nanoparticles caused little DNA damage and were non-toxic. Zinc oxide nanoparticles were slightly worse. Titanium dioxide caused only DNA damage. Carbon nanotubes caused DNA damage at low levels. Copper oxide was found to be the worst offender, and was the only nanomaterial identified by the researchers as a clear health risk.